Organogenesis Holdings Inc. (ORGO) |
|
3.75 -0.09 (-2.34%)
|
07-01 16:00 |
|
Open: |
3.84 |
Pre. Close: |
3.84 |
|
High:
|
3.85 |
Low:
|
3.75 |
|
Volume:
|
53,585 |
Market Cap:
|
398M |
|
|
|
|
Organogenesis Holdings Inc., a regenerative medicine company, focuses on the development, manufacture, and commercialization of solutions for the advanced wound care, and surgical and sports medicine markets primarily in the United States. The company's advanced wound care products include Apligraf for the treatment of venous leg ulcers and diabetic foot ulcers (DFUs); Dermagraft for treating DFUs; PuraPly AM to address biofilm across a range of wound types; and Affinity and NuShield to address various wound sizes and types. Its surgical and sports medicine products comprise ReNu for in-office joint and tendon applications; NuCel for bony fusion in the spine and extremities; NuShield and Affinity for surgical applications in targeted soft tissue repairs; and PuraPly AM for the surgical treatment of open wounds. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
3.859 - 3.878 |
3.878 - 3.893 |
|
Low:
|
3.698 - 3.723 |
3.723 - 3.744 |
|
Close:
|
3.714 - 3.753 |
3.753 - 3.784 |
|
Technical analysis |
as of: 2020-07-01 4:35:44 PM |
|
Overall:
|
 |
| Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell. |
| Target: |
Six months: 5.03  One year: 5.61 |
| Support: |
Support1: 3.50 Support2: 2.91 |
| Resistance: |
Resistance1: 4.30 Resistance2: 4.80 |
| Pivot: |
3.85  |
| Moving Average: |
MA(5): 3.82 MA(20): 3.92
MA(100): 3.71 MA(250): 4.91 |
| MACD: |
MACD(12,26): 0.01 Signal(9): 0.05 |
| Stochastic oscillator: |
%K(14,3): 46.11 %D(3): 42.05 |
| RSI: |
RSI(14): 47.19 |
| 52-week: |
High: 8.34 Low: 2.47 Change(%): -52.6 |
| Average Vol(K): |
3-Month: 18893 10-Days: 21744 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.ORGO has closed above bottom band by 17.6%. Bollinger Bands are 71.7% narrower than normal. The narrow width of the bands suggests low volatility as compared to ORGO's normal range. The bands have been in this narrow range for 9 bars. This is a sign that the market may be about to initiate a new trend. |
|
|
Headline News |
Mon, 29 Jun 2020
Organogenesis Holdings Inc. to Report Second Quarter of Fiscal Year 2020 Financial Results on August 10, 2020 - GlobeNewswire
Wed, 10 Jun 2020
Organogenesis (NASDAQ:ORGO) Downgraded by Zacks Investment Research to Sell - Stock Market Daily
Fri, 05 Jun 2020
Here is What Hedge Funds Think About Organogenesis Holdings Inc. (ORGO) - Yahoo Finance
Thu, 28 May 2020
Is Organogenesis Holdings Inc (ORGO) Stock a Good Buy on Thursday? - InvestorsObserver
Tue, 12 May 2020
Organogenesis Holdings Inc (ORGO) Q1 2020 Earnings Call Transcript - Motley Fool
Mon, 11 May 2020
Organogenesis Holdings Inc. Reports First Quarter 2020 Financial Results - GlobeNewswire
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
 |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
 |
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
|
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NasdaqCM |
| Sector: Healthcare |
| Industry: Drug ManufacturersSpecialty & Generic |
| Shares Out. (M) |
106 |
| Shares Float (M) |
12 |
|
% Held by Insiders
|
65.30 |
|
% Held by Institutions
|
27.61 |
|
Shares Short (K)
|
244 |
|
Shares Short P. Month (K)
|
290 |
Stock Financials |
|
EPS
|
-0.433 |
|
EPS Est This Year
|
|
|
EPS Est Next Year
|
|
|
Book Value (p.s.)
|
0.380 |
|
Profit Margin
|
-15.48 |
|
Operating Margin
|
-12.21 |
|
Return on Assets (ttm)
|
-10.5 |
|
Return on Equity (ttm)
|
-112.8 |
|
Qtrly Rev. Growth
|
8.1 |
|
Gross Profit (p.s.)
|
1.744 |
|
Sales Per Share
|
2.503 |
|
EBITDA (p.s.)
|
-0.223 |
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
-41 |
|
Levered Free Cash Flow (M)
|
-37 |
Stock Valuations |
|
PE Ratio
|
-8.66 |
|
PEG Ratio
|
|
|
Price to Book value
|
9.87 |
|
Price to Sales
|
1.50 |
|
Price to Cash Flow
|
-9.65 |
Stock Dividends |
|
Dividend
|
|
|
Forward Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
7 Binary Options
|
|
Your Ad Here
|
|
